AprilBio Co.,Ltd. (KOSDAQ:397030)

Market Cap	359.78B
Revenue	n/a
Net Income	n/a
Shares Out	22.49M
EPS	n/a
PE Ratio	n/a
Forward PE	42.90
Dividend	n/a
Ex-Dividend Date	n/a

Volume	27,948
Average Volume	142,390
Open	15,710
Previous Close	15,820
Day's Range	15,210 - 15,710
52-Week Range	11,980 - 25,900
Beta	1.58
RSI	56.99
Earnings Date	n/a

About AprilBio

AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics. The company develops products based on its long-acting protein medicine platform technology. It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases. The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2013
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 397030